Correlation Between Regen BioPharma and Allarity Therapeutics

Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regen BioPharma and Allarity Therapeutics, you can compare the effects of market volatilities on Regen BioPharma and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Allarity Therapeutics.

Diversification Opportunities for Regen BioPharma and Allarity Therapeutics

0.08

Correlation Coefficient

Regen BioPharma  Allarity Therapeutics

Significant diversification

The 3 months correlation between Regen and Allarity is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Allarity Therapeutics go up and down completely randomly.

Pair Corralation between Regen BioPharma and Allarity Therapeutics

Assuming the 90 days horizon Regen BioPharma is expected to generate 2.21 times more return on investment than Allarity Therapeutics. However, Regen BioPharma is 2.21 times more volatile than Allarity Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  6.27  in Regen BioPharma on December 20, 2024 and sell it today you would lose (0.27) from holding Regen BioPharma or give up 4.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	96.77%
Values	Daily Returns

Regen BioPharma  vs.  Allarity Therapeutics

Regen BioPharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Allarity Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Allarity Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak essential indicators, Allarity Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regen BioPharma and Allarity Therapeutics

The main advantage of trading using opposite Regen BioPharma and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.

The idea behind Regen BioPharma and Allarity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.